AzTrials
AzTrials

Gingiva DisorderNCT07316205

Gingival Pigmentation Intensity and Distribution Among Egyptians

An observational study of Gingiva Disorder, run by Assiut University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the present study is to evaluate the distribution, intensity and extension of gingival hyperpigmentation among a sample of Egyptian population. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Gingiva Disorder
What is being tested?
Evaluatation of the gingival pigmentation intensty and distribution
Type of treatment
Pill or oral medicine
How many people
70 participants
Where
1 siteEgypt
Study dates
20 Jan 2025to 20 Nov 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: population of any age except children that will seeking treatment at the dental clinics

Who may be able to join

  • Patients were free from any systemic disease as evidenced by Burkett's oral medicine health history questionnaire Greenberg et al.,2012.
  • Patients with physiologic gingival hyperpigmentation in the aesthetic zone.

Who cannot join

  • Smokers.
  • Pregnant and lactating women.
  • Drugs intake which associates with gingival melanin pigmentation such as Antimalarials drugs, phenothiazines and oral contraceptives.
  • Pathologies that cause gingival pigmentation (e.g.: Addison's disease, Albright's syndrome, Kaposi sarcoma)
  • Patients with periodontal disease.
  • Physical or mental impairment.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Assiut University

    Asyut, 71515

Other trials in Egypt

About this study

Official title: Beyond Pink: Assessing Gingival Pigmentation in the Egyptian Population: A Cross-Sectional Study

The aim of the present study is to evaluate the distribution, intensity and extension of gingival hyperpigmentation among a sample of Egyptian population.

Read the detailed description

After taking history \& clinical examination, three examiners will evaluate the gingival pigmentation in the anterior zone using the following indices:

Clinical evaluation:

Oral pigmentation index (DOPI):

This index of oral pigmentation is the commonly used index due to its simplicity and ease of use measure hyperpigmentation intensity. The scores are as follows:

  • No clinical pigmentation (pink-colored gingiva)
  • Mild clinical pigmentation (mild light brown color)
  • Moderate clinical pigmentation (medium brown or mixed pink and brown color)
  • Heavy clinical pigmentation (deep brown or bluish black color) Hedin melanin index for distribution of the pigmentation in the gingiva.

It is scored as:

0 = no gingival pigmentation.

  1. = one or two solitary units of interdental papillae are pigmented.
  2. = more than 3 separate units of interdental papillae are pigmented.
  3. = 1 short continuous band of pigmented gingiva.
  4. = one wideband continuous pigmented gingiva between the canines. The total scores of Hedin index of the mandible and maxilla will be obtained at baseline, one month, and six months after the depigmentation procedures. de Krom classification:

The de Krom classification will be conceived to assess pigmentation distribution. It includes six categories:

Category 1: Broad zone of pigmentation completely surrounds the dentition, displaying a clear apical contour. Apical to the mucogingival junction, the mucosa is pink. Gingival color can vary from dark to light brown. The zone is symmetric and the color uniform.

Category 2: Narrow zone of non-pigmented gingiva completely surrounds the teeth, that is, the marginal gingiva is pink. The remaining attached gingiva is as in Category 1, a broad zone of pig mentation. The zone is symmetric and the color uniform.

Category 3: Mucosa is completely pink, except for a thick or thin line of pigmentation at the level of the mucogingival junction. The pigmented zone is symmetric and the color uniform.

Category 4: Pigmentation is spread over the mucosa. It is asymmetric, patchy, and irregular. The color can be dark at one tooth and pink at the adjacent tooth.

Category 5: Mucosa is completely pink with the exception of a number of symmetric "islands" of pigmentation between anterior teeth. The patches are localized and dark, in contrast to the surrounding (pink) tissue. These patches do not extend to the gingiva. Category 6: Mucosa is completely pink and there are no signs of melanin pigmentation.

Being tested
Evaluatation of the gingival pigmentation intensty and distribution
Keywords
gingival pigmentation, egyptians
Medical subject headings
Gingival Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Evaluatation of the gingival pigmentation intensty and distributionOther

    After taking history \& clinical examination, three examiners will evaluate the gingival pigmentation in the anterior zone using the following indices:

    Clinical evaluation:

    Oral pigmentation index (DOPI) Dummet et al.,1967:

    This index of oral pigmentation is the commonly used index due to its simplicity and ease of use measure hyperpigmentation intensity. The scores are as follows:

    • No clinical pigmentation (pink-colored gingiva)
    • Mild clinical pigmentation (mild light brown color)
    • Moderate clinical pigmentation (medium brown or mixed pink and brown color)
    • Heavy clinical pigmentation (deep brown or bluish black color) Hedin melanin index (Hedin.,1977) for distribution of the pigmentation in the gingiva.

    It is scored as:

    0 = no gingival pigmentation.

    1. = one or two solitary units of interdental papillae are pigmented.
    2. = more than 3 separate units of interdental papillae are pigmented.
    3. = 1 short continuous band of pigmented
Study groups in NCT07316205
Study groupRoleWhat they receive
PatientsEvaluate the gingival pigmentation in the anterior zone using the Oral pigmentation index, Hedin melanin index and de Krom classification
Receives: Other: Evaluatation of the gingival pigmentation intensty and distribution

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pigmentation distribution

    to evaluate distribution of gingival pigmentation using Hedin melanin index and de Krom classification

    Hedin melanin index:

    Used for evaluation of the distribution of pigmentation in the gingiva. It is scored as 0= absence of gingival pigmentation.

    1. One or two isolated units of interdental papillae exhibit pigmentation.
    2. Three or more distinct units of interdental papillae exhibit pigmentation.
    3. continuous band of pigmented gingiva of short length. 4 = a broad band of continuous pigmented gingiva situated between the canines. de Krom classification: The de Krom classification has been invented to determine the distribution of pigmentation as follows:
    • Category 1: A wide band of pigmentation entirely encircles the dentition, exhibiting a distinct apical contour. The mucosa is pink above the mucogingival junction. The color of the gingiva may range from dark to light brown. The band is symmetrical, and its color is uniform.
    • Category 2: A narrow band of non-pigment

    Measured: baseline

  2. pigmentation intensity

    by using Dummet Oral Pigmentation Index (DOPI)

    This was used to evaluate the intensity of gingival pigmentation as follows:

    0= Absence of clinical pigmentation (pink-colored gingiva)

    1. Mild clinical pigmentation (light brown color)
    2. Moderate clinical pigmentation (medium brown or a combination of pink and brown color) 3 = Significant clinical pigmentation (dark brown or bluish-black color)

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2026
  2. Study start20 Jan 2025
  3. Primary completion20 Nov 2025
  4. Study completion20 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
70 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07316205
Sponsor's protocol ID
Gingival pigmentation
Status last verified
Jan 2026
First submitted
24 Nov 2025
Last updated
12 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Gingiva Disorder, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pigmentation distribution (time frame: baseline). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in